China NMPA Product Recall - Total Hip System

The National Medical Products Administration (NMPA) announced a global voluntary recall initiated by MicroPort Orthopedics, Inc., regarding its Total Hip System. Published on March 15, 2017, the recall stemmed from a critical manufacturing issue where the "BIOLOX FORTE 36mm Ceramic Femoral Head" component was found to be approximately 2mm shorter than specified when compared to other 36mm femoral heads (Cobalt Chrome and Biolox DELTA Ceramic). This dimensional discrepancy presents a significant risk of joint laxity and/or dislocation for patients, potentially requiring subsequent revision surgery. The issue was reported by Shanghai MicroPort Orthopedic Medical Technology Co., Ltd., the product's distributor in China. Despite the global scope, MicroPort Orthopedics, Inc. confirmed that no units of the affected product were sold or imported into the Chinese market. The NMPA directed all provincial Food and Drug Administrations to enhance their supervision and management of similar medical devices to ensure patient safety.